Doctor profile · Federal record
Dr. BENJAMIN LOCKSHIN, MD
Dermatology Physician (CMS: DERMATOLOGY) · Dermatology Physician · SILVER SPRING, MD
- NPI 1275523110
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 25 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10313 GEORGIA AVE, SUITE 309
SILVER SPRING, MD 209025006
(301) 681-7000 - Mailing address
-
10313 GEROGIA AVE, SUITE 309
SILVER SPRING, MD 209025006
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- March 12, 2014
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Maryland #D0063751 · Ohio #35-086442
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275523110. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,352
Distinct HCPCS
10
Medicare allowed
$477,649
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,214 | 491 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,324 | 994 | $103 | |
17000 |
Destruction of precancer skin growth, 1 growth | 911 | 710 | $64 | |
11102 |
Biopsy of related skin growth, first growth | 479 | 435 | $113 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 472 | 352 | $146 | |
17110 |
Destruction of skin growth, 1-14 growths | 188 | 170 | $134 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 187 | 187 | $127 | |
11103 |
Biopsy of related skin growth, each additional growth | 173 | 120 | $60 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 48 | 33 | $171 | |
10060 |
Simple or single drainage of skin abscess | 43 | 41 | $145 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 165. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$752,763
Transactions
634
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 73 | $157,978.81 | |
| ABBVIE INC. | 92 | $101,540.27 | |
| Regeneron Healthcare Solutions, Inc. | 57 | $98,213.78 | |
| UCB, Inc. | 80 | $88,958.83 | |
| Dermavant Sciences, Inc. | 73 | $79,266.37 | |
| Arcutis Biotherapeutics, Inc. | 58 | $75,958.82 | |
| E.R. Squibb & Sons, L.L.C. | 56 | $71,201.98 | |
| Incyte Corporation | 45 | $37,991.29 | |
| Lilly USA, LLC | 38 | $24,782.93 | |
| Galderma Laboratories, L.P. | 17 | $7,531.75 | |
| Eli Lilly and Company | 1 | $4,800.00 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $3,570.43 | |
| Novartis Pharmaceuticals Corporation | 17 | $379.52 | |
| PFIZER INC. | 17 | $150.87 | |
| LEO Pharma Inc. | 5 | $134.32 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
718
Patients
361
Total drug cost
$1,091,238
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 151 | 87 | $10,723 |
| Triamcinolone Acetonide | Generic | 131 | 101 | $1,323 |
| Tacrolimus | Generic | 59 | 48 | $13,044 |
| Dupixent Pen (Dupilumab) | Brand | 53 | 0 | $197,051 |
| Fluorouracil | Generic | 46 | 44 | $3,539 |
| Minoxidil | Generic | 40 | 18 | $711 |
| Taltz Autoinjector (Ixekizumab) | Brand | 37 | 0 | $251,800 |
| Ketoconazole | Generic | 31 | 15 | $630 |
| Doxycycline Hyclate | Generic | 30 | 20 | $1,110 |
| Cosentyx Sensoready (2 Pens) (Secukinumab) | Brand | 29 | 0 | $227,358 |